JAZZ vs PFGC Comparison

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Performance Food Group is one of the largest foodservice distributors in the US, with sales of more than $63 billion in fiscal 2025. It sells and distributes food and nonfood products through its foodservice segment, which serves restaurants and institutions, accounting for 53% of sales. PFG also wholesales and distributes products to convenience stores (39%) and through its specialty segment (8% of sales), which serves customers such as vending operators, office coffee service providers, and theaters. The firm's platform spans 250,000 products offered to 300,000 customer locations, supported by 155 distribution centers across all three segments.